In this longevity-investing focused webinar, Dr. Slawin will be presenting Eos SENOLYTIX, giving a sneak preview of the groundbreaking data he will be presenting in March at the International Conference…

Building on the first Founders Longevity Forum held in June in London, at which Dr. Slawin brought our company out of five years of “stealth mode” to present our company...

“Novel Gerotherapeutic Peptide PTC-2105 Reverses the Aging Phenotype In Naturally Aged Mice” Task Force on Pre-Clinical and Clinical Trials 2025 – oral communication 2:20 – 2:40 P.M. local time (8:20...

“Novel Gerotherapeutic Peptides Alleviate Sarcopenia and Frailty In Naturally Aged Mice By Dual Mechanisms Acting Through a Single Aging-Selective Target” International Conference on Frailty and Sarcopenia Research 2025 – oral…

At the Founders Longevity Forum in London on June 10-11, 2024, Dr. Slawin brought our company out of five years of “stealth mode” to present our company publicly for the…